Superworth

Viking Therapeutics shares outstanding VKTX

Diluted shares outstanding, averaged over each quarter, from 2014.

Latest quarter, to Sep 30, 2026
118M
On a year earlier
+5.1%
more shares

Viking Therapeutics had 118M diluted shares outstanding on average in Q3 FY26, the quarter to Sep 30, 2026.

That is 5.1% more than a year earlier, so each share owns a little less of the company.

Shares outstanding over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearShares, fourth quarterChange
FY2025114M+2%
FY2024111.3M+11%
FY202399.9M+30%
FY202276.6M−2%
FY202178.1M+7%
FY202072.9M+1%
FY201972.1M+1%
FY201871.3M+139%
FY201729.9M+50%
FY201619.9M+296%
FY20155M+5%
FY20144.8Mn/a

Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.

Quarter by quarter

QuarterEndedShares outstandingOn a year earlier
Q3 FY26118M+5%
Q2 FY26116.3M+4%
Q1 FY26115.6M+3%
Q4 FY25114M+2%
Q3 FY25112.3M+1%
Q2 FY25112.1M+2%
Q1 FY25112.1M+8%
Q4 FY24111.3M+11%
Q3 FY24110.9M+11%
Q2 FY24110.4M+11%
Q1 FY24103.5M+32%
Q4 FY2399.9M+30%

What the shares outstanding tells you

Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.

A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.

More on Viking Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.